| Terminated | 3 | 52 | Europe, US, RoW | Enobosarm, VERU-024, Exemestane, Mestane | Veru Inc. | Metastatic Breast Cancer | 01/24 | 01/24 | | |
SUNRAY-01, NCT06119581: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer |
|
|
| Recruiting | 3 | 1016 | Europe, Canada, Japan, US, RoW | LY3537982, Olomorasib, Pembrolizumab, Placebo, Cisplatin, Carboplatin, Pemetrexed | Eli Lilly and Company, Loxo Oncology, Inc. | Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis | 10/26 | 10/29 | | |
NCT05271292: Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. |
|
|
| Recruiting | 1/2 | 36 | US | Chiauranib, CS2164 | Chipscreen Biosciences, Ltd. | Small Cell Lung Cancer, Advanced Solid Malignant Tumor | 03/25 | 05/25 | | |
